Department of Cardiology, Keio University School of Medicine, Tokyo, Japan; Department of Cardiology, Japanese Red Cross Ashikaga Hospital, Tochigi, Japan.
Department of Cardiology, Keio University School of Medicine, Tokyo, Japan.
J Cardiol. 2021 Nov;78(5):431-438. doi: 10.1016/j.jjcc.2021.05.016. Epub 2021 Jun 23.
Sex differences in the outcomes following percutaneous coronary intervention (PCI) for acute coronary syndrome (ACS) have been identified in Western countries. However, data on the long-term outcomes for bleeding events, particularly in East Asia where the aging population is growing rapidly and consists predominantly of women, remain scarce.
We analyzed 2,494 ACS survivors from a multicenter PCI registry who underwent PCI between 2009 and 2012. The primary outcome was readmission for major bleeding at 2 years. Survival curves were generated with the cumulative incidence function. The adjusted hazard ratios were evaluated for the primary outcomes by sex using (1) Fine-Gray models and (2) Cox regression models.
There were 548 women (22.0%) in this cohort. The women were older (73.7 ± 10.8 years vs. 65.4 ± 11.8 years, p < 0.001), had a lower body mass index (23.0 ± 3.9 vs. 24.3 ± 3.6, p < 0.001), and had more comorbidities such as renal failure (49.4% vs. 36.3%, p < 0.001) and previous heart failure (8.4% vs. 4.5%, p < 0.001). Fewer women were discharged with statins (81.9% vs. 86.5%, p = 0.025) or beta blockers (70.6% vs. 77.1%, p = 0.007). During the 2-year follow-up, the unadjusted readmission rates for bleeding were higher among women (4.9% versus 2.4% at 2 years after discharge). Multivariable competing risk analysis with the Fine-Gray model and Cox regression model further demonstrated that female sex was associated with a higher risk of bleeding.
Among patients treated with PCI, women had a higher incidence of bleeding events requiring readmission. Sex disparities in the etiologies of readmission following PCI suggest the need for targeted treatment strategies. A strict follow-up after discharge could be beneficial for women to further reduce their risk.
在西方国家,经皮冠状动脉介入治疗(PCI)治疗急性冠状动脉综合征(ACS)的结果存在性别差异。然而,在东亚,人口老龄化迅速增长且以女性为主,有关出血事件的长期结果的数据仍然很少。
我们分析了 2009 年至 2012 年间在多中心 PCI 注册中心接受 PCI 的 2494 例 ACS 幸存者。主要结果是 2 年内因大出血再次入院。使用累积发生率函数生成生存曲线。使用(1)Fine-Gray 模型和(2)Cox 回归模型,按性别评估主要结局的调整后的风险比。
该队列中有 548 名女性(22.0%)。女性年龄较大(73.7 ± 10.8 岁 vs. 65.4 ± 11.8 岁,p < 0.001),体重指数较低(23.0 ± 3.9 vs. 24.3 ± 3.6,p < 0.001),合并症较多,如肾衰竭(49.4% vs. 36.3%,p < 0.001)和既往心力衰竭(8.4% vs. 4.5%,p < 0.001)。出院时接受他汀类药物(81.9% vs. 86.5%,p = 0.025)或β受体阻滞剂(70.6% vs. 77.1%,p = 0.007)的女性较少。在 2 年的随访期间,女性未经调整的出血再入院率较高(出院后 2 年时为 4.9% vs. 2.4%)。Fine-Gray 模型和 Cox 回归模型的多变量竞争风险分析进一步表明,女性性别与出血风险增加相关。
在接受 PCI 治疗的患者中,女性出血事件再入院率较高。PCI 后再入院的性别差异表明需要有针对性的治疗策略。出院后严格随访可能对女性进一步降低风险有益。